These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27149990)

  • 21. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer.
    Treekitkarnmongkol W; Katayama H; Kai K; Sasai K; Jones JC; Wang J; Shen L; Sahin AA; Gagea M; Ueno NT; Creighton CJ; Sen S
    Carcinogenesis; 2016 Dec; 37(12):1180-1189. PubMed ID: 27624071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors.
    Chiche A; Moumen M; Romagnoli M; Petit V; Lasla H; Jézéquel P; de la Grange P; Jonkers J; Deugnier MA; Glukhova MA; Faraldo MM
    Oncogene; 2017 Apr; 36(17):2355-2365. PubMed ID: 27775073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine microenvironment metaprofiles associate with human cancer etiology and intrinsic subtypes.
    Nguyen DH; Fredlund E; Zhao W; Perou CM; Balmain A; Mao JH; Barcellos-Hoff MH
    Clin Cancer Res; 2013 Mar; 19(6):1353-62. PubMed ID: 23339125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk.
    Blackburn AC; Hill LZ; Roberts AL; Wang J; Aud D; Jung J; Nikolcheva T; Allard J; Peltz G; Otis CN; Cao QJ; Ricketts RS; Naber SP; Mollenhauer J; Poustka A; Malamud D; Jerry DJ
    Am J Pathol; 2007 Jun; 170(6):2030-41. PubMed ID: 17525270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer.
    Hollern DP; Contreras CM; Dance-Barnes S; Silva GO; Pfefferle AD; Xiong J; Darr DB; Usary J; Mott KR; Perou CM
    Breast Cancer Res Treat; 2019 Feb; 174(1):143-155. PubMed ID: 30484104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional Mediator.
    McDaniel JM; Morrissey RL; Dibra D; Patel LR; Xiong S; Zhang Y; Chau GP; Su X; Qi Y; El-Naggar AK; Lozano G
    Cancer Res Commun; 2024 Aug; 4(8):1991-2007. PubMed ID: 38994678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic structural rearrangements in genetically engineered mouse mammary tumors.
    Varela I; Klijn C; Stephens PJ; Mudie LJ; Stebbings L; Galappaththige D; van der Gulden H; Schut E; Klarenbeek S; Campbell PJ; Wessels LF; Stratton MR; Jonkers J; Futreal PA; Adams DJ
    Genome Biol; 2010; 11(10):R100. PubMed ID: 20942901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer.
    Liu H; Murphy CJ; Karreth FA; Emdal KB; White FM; Elemento O; Toker A; Wulf GM; Cantley LC
    Cancer Discov; 2018 Mar; 8(3):354-369. PubMed ID: 29203461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ATF3-Induced Mammary Tumors Exhibit Molecular Features of Human Basal-Like Breast Cancer.
    Yan L; Gaddis S; Coletta LD; Repass J; Powell KL; Simper MS; Chen Y; Byrom M; Zhong Y; Lin K; Liu B; Lu Y; Shen J; MacLeod MC
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of Brca1 and Trp53 in adult mouse mammary ductal epithelium results in development of hormone receptor-positive or hormone receptor-negative tumors, depending on inactivation of Rb family proteins.
    Szabova L; Gordon MB; Lu L; Pate N; Bassel L; Iacovelli AJ; Karim B; Homan PJ; Householder DB; Guerin TM; Burkett S; Day AM; Custer W; Weaver Ohler Z
    Breast Cancer Res; 2022 Nov; 24(1):75. PubMed ID: 36333737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line.
    Sharp JA; Mailer SL; Thomson PC; Lefèvre C; Nicholas KR
    Mol Cancer; 2008 Jan; 7():1. PubMed ID: 18179684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crucial and novel cancer drivers in a mouse model of triple-negative breast cancer.
    Johnson JP; Kumar P; Koulnis M; Patel M; Simin K
    Cancer Genomics Proteomics; 2014; 11(3):115-26. PubMed ID: 24969692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34.
    Abba MC; Fabris VT; Hu Y; Kittrell FS; Cai WW; Donehower LA; Sahin A; Medina D; Aldaz CM
    Cancer Res; 2007 May; 67(9):4104-12. PubMed ID: 17483321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
    Deeb KK; Michalowska AM; Yoon CY; Krummey SM; Hoenerhoff MJ; Kavanaugh C; Li MC; Demayo FJ; Linnoila I; Deng CX; Lee EY; Medina D; Shih JH; Green JE
    Cancer Res; 2007 Sep; 67(17):8065-80. PubMed ID: 17804718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of BCCIP deficiency in mammary tumorigenesis.
    Droz-Rosario R; Lu H; Liu J; Liu NA; Ganesan S; Xia B; Haffty BG; Shen Z
    Breast Cancer Res; 2017 Oct; 19(1):115. PubMed ID: 29047390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mammary-specific, long-range deletion on mouse chromosome 11 accelerates Brca1-associated mammary tumorigenesis.
    Triplett AA; Montagna C; Wagner KU
    Neoplasia; 2008 Dec; 10(12):1325-34. PubMed ID: 19048111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-species oncogenic signatures of breast cancer in canine mammary tumors.
    Kim TM; Yang IS; Seung BJ; Lee S; Kim D; Ha YJ; Seo MK; Kim KK; Kim HS; Cheong JH; Sur JH; Nam H; Kim S
    Nat Commun; 2020 Jul; 11(1):3616. PubMed ID: 32680987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative epigenomics of human and mouse mammary tumors.
    Demircan B; Dyer LM; Gerace M; Lobenhofer EK; Robertson KD; Brown KD
    Genes Chromosomes Cancer; 2009 Jan; 48(1):83-97. PubMed ID: 18836996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor.
    Pfefferle AD; Darr DB; Calhoun BC; Mott KR; Rosen JM; Perou CM
    Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31213486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.